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Abstract 
Background: Schistosomes are trematode worms that dwell in their definitive host’s blood vessels, where females 
lay eggs that need to be discharged into the environment with host excreta to maintain their life-cycle. Both worms 
and eggs require type 2 immunity for their maturation and excretion, respectively. However, the immune molecules 
that orchestrate such immunity remain unclear. Interleukin (IL)-33 is one of the epithelium-derived cytokines that 
induce type 2 immunity in tissues. The aim of this study was to determine the role of IL-33 in the maturation, repro-
duction and excretion of Schistosoma mansoni eggs, and in the maintenance of egg-induced pathology in the intes-
tines of mice.
Methods: The morphology of S. mansoni worms and the number of eggs in intestinal tissues were studied at dif-
ferent time points post-infection in S. mansoni-infected IL-33-deficient (IL-33−/−) and wild-type (WT) mice. IL-5 and 
IL-13 production in the spleens and mesenteric lymph nodes were measured. Tissue histology was performed on the 
terminal ilea of both infected and non-infected mice.
Results: Worms from IL-33−/− and WT mice did not differ morphologically at 4 and 6 weeks post-infection (wpi). 
The number of eggs in intestinal tissues of IL-33−/− and WT mice differed only slightly. At 6 wpi, IL-33−/− mice 
presented impaired type 2 immunity in the intestines, characterized by a decreased production of IL-5 and IL-13 in 
mesenteric lymph nodes and fewer inflammatory infiltrates with fewer eosinophils in the ilea. There was no difference 
between IL-33−/− and WT mice in the levels of IL-25 and thymic stromal lymphopoietin (TSLP) in intestinal tissues.
Conclusions: Despite its ability to initiate type 2 immunity in tissues, IL-33 alone seems dispensable for S. mansoni 
maturation and its absence may not affect much the accumulation of eggs in intestinal tissues. The transient impair-
ment of type 2 immunity observed in the intestines, but not spleens, highlights the importance of IL-33 over IL-25 
and TSLP in initiating, but not maintaining, locally-induced type 2 immunity in intestinal tissues during schistosome 
infection. Further studies are needed to decipher the role of each of these molecules in schistosomiasis and clarify the 
possible interactions that might exist between them.
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Background
Schistosomes are blood-dwelling trematode worms that 
affect over 250  million people in the world, of whom 
201.5 million live in sub-Saharan Africa [1]. Among the 
several schistosome species that exist, three, namely 
Schistosoma haematobium, S. japonicum and S. man-
soni, are the main cause of schistosomiasis in humans [2]. 
The first of these causes urogenital schistosomiasis and 
the latter two cause hepato-splenic schistosomiasis [2]. 
Schistosoma haematobium worms live in perivesical vein 
plexuses, and S. japonicum and S. mansoni live in mes-
enteric veins, where females lay hundreds to thousands 
of eggs per day [3]. About half of these eggs are washed 
into the liver by blood flow from the mesenteric veins; of 
the remainder, one-third to one-half succeed in reach-
ing the intestinal lumen to be discharged into the envi-
ronment with the host’s feces, while  the remaining eggs 
are  trapped in intestinal tissues where they die, either 
killed by the host’s immune system or of natural death [4, 
5].
Through their excretory–secretory products (ESP), 
such as the interleukin (IL)-4-inducing principle of S. 
mansoni eggs (IPSE/α1) [6, 7] and omega-1 (ω1) [8] from 
S. mansoni and their homologs from S. haematobium [9] 
and S. japonicum [10], tissue-trapped eggs elicit strong 
and vigorous type 2 cell-mediated immunity that induces 
perioval granuloma formation and leads to fibrosis [11, 
12], pathological characteristics of a patent schistosome 
infection. While this immune response is thought to be 
beneficial for the host, especially in the liver where it may 
protect hepatic cells from toxic effects of egg-derived 
ESP, it also plays a major role in the development of liver 
pathology [13]. In contrast, in addition to being protec-
tive for and yet smiting the host with the pathology, gran-
ulomas in intestines play a beneficial role for the parasite, 
favoring the escape of eggs from the host through the 
intestinal wall [14, 15].
Eggs are not the sole inducers of type 2 immunity in 
schistosomiasis, as studies have reported type 2 immune 
responses during prepatent schistosomiasis infection 
before egg deposition by female worms begins [16, 17]. 
The type 2 immunity during the prepatent schistosome 
infection was later found to be essential for the matura-
tion of the worms, as the injection of IL-4, the T-helper 
2 (Th2) polarizing cytokine, in schistosome-infected 
recombination activating gene (RAG)-deficient mice, 
in which schistosome worms fail to mature and repro-
duce due to the lack of functional  CD4+ T cells, restored 
the worm maturation process and egg deposition [18].
Emerging evidence indicates that the induction of type 
2 immunity in tissues is not solely dependent on IL-4, 
with type 2 immunity shown also to be induced through 
the activation of group 2 innate lymphoid cells (ILC2) by 
the epithelium-derived cytokines IL-25, IL-33 and thymic 
stromal lymphopoietin (TSLP). Activated ILC2, in turn, 
produce abundant amounts of type 2 effector cytokines 
IL-4, IL-5, IL-9 and IL-13 [19–22] and, through the 
expression of the class II major histocompatibility com-
plex (MHC II) [23] and OX40L [24], interact with  CD4+ 
T cells to potentiate such type 2 immune responses. ILC2 
were also found to initiate the adaptive type 2 immunity 
in an IL-4-independent manner by inducing IL-13-de-
pendent activation and migration of dendritic cells to the 
draining lymph nodes where they polarize naïve  CD4+ T 
cells into Th2 cells [25].
However, the role of ILC2-activating cytokines IL-25, 
IL-33 and TSLP in schistosomiasis remains less under-
stood. Focusing on the liver pathogenesis during S. 
japonicum infection, two studies showed that IL-33 con-
tributes to the development of pathology via the induc-
tion of type 2 immune responses in infected mice [26, 
27]. Indeed, studies have shown that IL-33 plays a critical 
role in the development of liver pathology through the 
alternative activation of macrophages (M2) [27] and the 
activation of hepatic stellate cells by ILC2-derived IL-13 
[28]. Moreover, Yu et al. [26] found that the injection of 
exogenous IL-33 into S. japonicum-infected mice led to 
an increased worm burden at the sixth week of infection 
without affecting their fecundity, suggesting that IL-33 
might play a role in the migration and maturation of 
schistosome worms. Whether endogenous IL-33 plays a 
role in schistosome maturation and reproduction is not 
known.
As IL-33 is known to induce and/or amplify M2 polari-
zation of macrophages [27, 29–31] which are essential for 
the excretion of schistosome eggs [14, 15], we considered 
the possibility that in addition to contributing to the mat-
uration of schistosome worms through the induction of 
type 2 immunity during prepatent schistosome infection, 
IL-33 may also play a role in the accumulation of S. man-
soni eggs in the intestinal tissues. We hypothesized that 
IL-33 deficiency would impair the maturation of S. man-
soni worms and possibly also lead to the accumulation of 
more eggs in the intestinal tissues [14, 32, 33], and that 
type 2 immunity would be impaired in the absence of 
IL-33. In the study reported here, we show that IL-33 is in 
fact dispensable for the maturation of S. mansoni worms 
and that its absence does not affect much the number of 
eggs accumulated in the intestinal tissues. Also, our find-
ings support the notion that IL-33 might be most potent 
in initiating, but not maintaining, type 2 immunity in tis-
sues and that to maintain type 2 immunity once initiated, 
IL-33 may need the synergy of IL-25 and TSLP and/or of 
 CD4+ Th2-derived effector cytokines.
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Methods
Parasite, mice and infection
A Puerto Rican strain of S. mansoni was maintained 
in the laboratory by passage between Biomphalaria 
glabrata snails and ICR mice. BALB/cCrSlc (hereinafter 
referred to as BALB/c) mice were purchased from Japan 
SLC (Hamamatsu, Shizuoka, Japan) and maintained in 
specific pathogen-free conditions at Nagasaki University 
animal facilities. Provided by Professor Satoshi Uematsu 
(Osaka City University Graduate School of Medicine, 
Osaka, Japan), IL-33−/− mice on the BALB/c background 
were bred and maintained in the same conditions as for 
WT BALB/c mice at Nagasaki University animal facili-
ties. All mice were provided with water and food ad libi-
tum. Female mice aged 8–12 weeks were subcutaneously 
infected [34] with 50 and 35 freshly shed S. mansoni cer-
cariae for 9 and 12 weeks, respectively. Mice were sacri-
ficed every 3  weeks from week 6 post-infection (6 wpi) 
onwards, except for worm morphology assessment where 
mice were also sacrificed at 4 wpi. To assess the produc-
tion of IL-25, IL-33 and TSLP in intestinal tissues during 
S. mansoni infection, WT BALB/c mice were infected 
with S. mansoni cercariae as described above and sacri-
ficed weekly from week 0 to week 4 post-infection, then 
every 2 weeks to 12 wpi.
Worm morphology and number
Adult S. mansoni worms were obtained by portal vein 
perfusion and fixed with 4% neutral buffered forma-
lin (NBF) [35], following which their morphology was 
assessed under an inverted light microscope at 40× mag-
nification and their number counted. Briefly, the portal 
vein was cut at its base under the liver, then the left car-
diac ventricle was perfused with 30 mL of saline citrate 
(7.5 g of sodium citrate and 8.5 g of sodium chloride in 
milliQ) [34], followed by perfusion with 30 mL of phos-
phate buffered saline (PBS). The mesenteric veins were 
thoroughly checked for manual retrieval of worms that 
failed to wash out during perfusion.
Tissue eggs and eggs per worm pair numbers
Livers and intestines were harvested and digested with 
4% KOH at 37  °C for 14  h. Briefly, livers were weighed 
and digested with 10 mL of 4% KOH, and intestines were 
cleansed of fecal matters, opened longitudinally, thor-
oughly washed with PBS, weighed and then digested as 
described for livers [34]. After digestion, samples were 
centrifuged for 5 min at 2000 rpm and room temperature. 
Eggs were counted in 50  µL of thoroughly mixed pellet 
suspension under the light microscope at 40× magnifica-
tion and related to the organ weight. The number of eggs 
per worm pair was obtained by dividing the total number 
of tissue eggs per mouse by the number of worm pairs 
from the same mouse.
Egg isolation and production of S. mansoni soluble egg 
antigen
Eggs were isolated from the livers of S. mansoni-infected 
ICR mice and frozen at − 30 °C until use. Briefly, 8 weeks 
after infection with 200 S. mansoni cercariae, livers of 
the infected mice were removed after the portal perfu-
sion, washed with PBS, minced with sterile scissors and 
then homogenized in 1× PBS using the IKA T25 digital 
Ultra Turrax homogenizer (IKA-Werke GmbH & Co., 
Staufen, Germany). The homogenates were centrifuged 
for 5  min at 1500  rpm and room temperature, digested 
twice at 37 °C with shaking at 120 rpm, first with 1 mg/
mL of Actinase E (Funakoshi, Tokyo, Japan) for 3 h, then 
with 0.1  mg/mL of Actinase E (Funakoshi) and 0.5  mg/
mL of collagenase (Wako Pure Chemicals, Osaka, Japan) 
for 2 h. Obtained egg suspensions were filtered through a 
series of sieves (425, 180, 106 and 45 µm) [34]. The eggs 
retained on the smallest sieve (45 µm) were washed onto 
a Petri dish [29]. By swirling the dish, mature eggs were 
concentrated in the center of the dish and collected with 
a wide-bore pipette tip [34]. After settling, the superna-
tant was discarded and eggs were dry frozen at − 30  °C 
until use.
For the production S. mansoni soluble egg antigen 
(SmSEA), frozen eggs were thawed on ice, resuspended 
in ice-cold PBS containing 10  µg/mL of leupeptin, then 
homogenized on ice using a handheld sterile glass Tef-
lon homogenizer. The homogenate was subjected to five 
freeze (− 80°C) and thaw (on ice) cycles, incubated at 
4 °C overnight with rotation, then centrifuged for 1 h at 
30,000 g and 4 °C. The supernatant was collected in new 
tubes on ice, dialyzed in PBS three times at 4 °C for 2 and 
4 h and overnight, respectively, by using a Slide-A-Lyzer 
Dialysis Cassette (Thermo Fisher Scientific, Rockford IL, 
USA) as per the manufacturer’s instructions. The pro-
tein concentration was determined by the Bicinchoninic 
acid (BCA) method (Pierce BCA Protein Assay, Thermo 
Fisher Scientific). The solution was filter-sterilized 
through a 0.2-µm filter, aliquoted and stored at − 30  °C 
until use.
Cell stimulation and cytokine measurement
Immune cells were isolated from spleens and mesen-
teric lymph nodes (MLNs) of infected and non-infected 
wild-type (WT) and IL-33−/− mice and stimulated 
with SmSEA. Briefly, spleens were crushed and filtered 
through a 70-µm-mesh cell strainer, washed with Hank’s 
balanced salt solution (HBSS), then resuspended in 
complete RPMI medium (containing 10% fetal bovine 
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serum, 100  units/mL of penicillin and 100  µg/mL of 
streptomycin, 55  µM of 2-mercaptoethanol, HEPES 
[4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid] 
and l-glutamine). MLNs were then filtered through a 
40-µm-mesh cell strainer and processed as above. The 
cells (1.0 × 106  cells per well) were plated in a flat bot-
tomed 96-well plate, stimulated with 50 µg/mL of SmSEA 
in a 5%  CO2 incubator at 37 °C for 72 h. The plates were 
then stored at − 30  °C until use. The concentrations of 
IL-5 and IL-13 were measured in the culture superna-
tants by an enzyme-linked immunosorbent assay (ELISA) 
as per the manufacturer’s instructions (DuoSet ELISA; 
R&D Systems, Minneapolis, MN, USA).
Tissue cytokines
Small intestines were harvested in ice-cold PBS. After 
fecal matter had been removed, the intestines were 
opened along their axis, thoroughly washed with ice-
cold PBS, cut into small pieces and homogenized in 
3  mL of ice-cold HBSS (containing 10  µg/mL of leu-
peptin and 0.1  mM/mL of phenylmethylsulfonyl fluo-
ride) with the  gentleMACS Octo Dissociator  (Miltenyi 
Biotec GmbH, Bergisch Gladbach, Germany) using the 
Protein_01 program. The homogenates were then cen-
trifuged for 20  min at 20,000  g and 0  °C [36], and the 
supernatants were collected, aliquoted and stored at 
− 30 °C until use. The concentrations of IL-25, IL-33 and 
TSLP were measured in the supernatants by an ELISA 
according to the manufacturer’s instructions (DuoSet 
ELISA; R&D Systems, Inc.).
Histology
A 1-cm-long fragment of terminal ileum was cut from 
each mouse, close to the secum of both infected and non-
infected mice, cleaned of fecal matter and fixed in 10% 
NBF until use. Samples were sent to the Division of Cell 
Function Research Support, Biomedical Research Sup-
port Center at Nagasaki University School of Medicine, 
for tissue processing. Slide-embedded hematoxylin and 
eosin-stained tissue sections were scanned at 40× mag-
nification using Aperio CS2 Scanner (Leica Biosystems 
Imaging, Leica Biosystems, CA, USA), and digital images 
were analyzed using Aperio ImageScope version 12.4.3 
software (Leica Biosystems Imaging, Leica Biosystems). 
The number and size of granuloma areas were counted 
and measured, respectively. The intestinal wall thickness 
was measured at three different places. The abundance of 
eosinophils in the inflammatory infiltrates was visually 
determined. All of the measurement results were com-
pared between IL-33−/− and WT.
Statistical analysis
Data normality was determined by the Shapiro–Wilk 
test. Using GraphPad Prism version 8.4.2 for Windows 
(GraphPad Software, San Diego, CA, USA), we per-
formed Welch’s t-test or the Mann-Whitney U-test to 
compare IL-33−/− and WT mice. Statistical significance 
was set at P < 0.05. Unless otherwise stated, all data are 
presented as mean with standard error of the mean and 
are representative of at least two independent experi-
ments with similar results.
Results
IL‑33 deficiency does not affect S. mansoni worm 
maturation and the number of eggs in intestinal tissues
Schistosome worms are characterized by their depend-
ence on the host immune system, particularly type 2 
immunity, for their maturation, reproduction and egg 
excretion [15, 18, 35, 37], indicating the importance of 
type 2 immunity in the biology of schistosomes. Because 
IL-33 is known to induce type 2 immunity independently 
of IL-4 [38] and in light of the results of a recent study 
[26] which reported increased S. japonicum worm num-
bers after injection of exogenous IL-33 into infected 
mice, we decided to investigate whether IL-33 deficiency 
would compromise the maturation of S. mansoni worms 
by comparing the morphology and number of worm 
pairs between IL-33−/− and WT mice. We therefore 
infected IL-33−/− and WT BALB/c mice with S. mansoni 
cercariae and sacrificed them at indicated post-infec-
tion time points (Fig. 1a). As shown in Fig. 1b, in terms 
of morphology, there was no difference between worms 
recovered from IL-33−/− and those recovered from WT 
mice. Although the number of worm pairs tended to be 
higher in IL-33−/− mice during the course of infection, 
this difference was statistically significant only at the 
ninth week of infection (U = 0.5, P = 0.0065; Fig. 1c). The 
number of eggs per worm pair, calculated by dividing 
the raw number of worm pairs by the raw number of tis-
sue (liver and intestinal) eggs, seemed to be comparable 
between IL-33−/− and WT mice during the whole course 
of infection (t(5) = 0.184, P = 0.861; t(9) = 1.972, P = 0.081; 
t(3) = 0.919, P = 0.423, at 6, 9 and 12  wpi, respectively; 
Additional file 1: Figure S1a).
To evaluate whether IL-33 deficiency may affect the 
accumulation of eggs in the intestinal tissues, we com-
pared the number of eggs in intestinal tissues between 
IL-33−/− and WT mice every 3  weeks from week 6 to 
week 12 post infection. Similar to the observations on 
the number of worm pairs, the number of eggs in intes-
tinal tissues tended to be higher in IL-33−/− mice than 
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in WT mice (Fig.  1d), but no statistical difference was 
found between both mouse genotypes (U = 3, P = 0.2; 
U = 18, P = 0.281; U = 5, P = 0.285 at 6, 9 and 12  wpi, 
respectively). Because several previous studies had 
reported a pathogenic role for IL-33 in egg-induced 
liver pathology by an increased number of liver tis-
sue eggs [26, 27], we investigated whether IL-33 defi-
ciency would affect the number of eggs in liver tissues 
of IL-33−/− compared to WT mice. We found that 
although IL-33−/− mice tended to have higher number 
of eggs than WT mice (Additional file  1: Figure S1b), 
there was no statistical difference in liver egg numbers 
between both mouse genotypes (t(4) = 2.097, P = 0.097; 
t(9) = 0.397, P = 0.7; t(4) = 1.298, P = 0. 2653 at 6, 9 and 
12  wpi, respectively). Taken together, these data indi-
cate that IL-33 is dispensable for the maturation of S. 
mansoni worms and that its absence may have a negli-
gible effect on the accumulation of eggs in the intestinal 
tissues.
IL‑33 deficiency is associated with transitory impairment 
of type 2 immunity in mesenteric lymph nodes of S. 
mansoni‑infected mice
Compared with IL-25 and TSLP, IL-33 is known to be the 
stronger molecule for inducing type 2 immunity through 
the activation of ILC2 and macrophages [39, 40]. There-
fore, we assessed whether IL-33 deficiency would impair 
type 2 immunity in intestines. We isolated immune 
cells from MLNs of S. mansoni-infected IL-33−/− and 
WT mice, stimulated them with SmSEA for 72  h and 
then measured IL-5 and IL-13 cytokines by ELISA. 
As expected, IL-33 deficiency impaired the produc-
tion of IL-5 and IL-13 in the MLNs of infected mice in 
response to stimulation with SmSEA at 6 weeks of infec-
tion (t(8) = 6.595, P = 0.0002 for IL-5 and U = 2, P = 0.008 
for IL-13; Fig. 2a, b). However, this impairment was not 
sustained during the course of infection as it disappeared 
at subsequent infection time points (U = 6, P = 0.6857; 
U = 1, P = 0.4 for IL-5 and U = 3, P = 0.2; U = 1, P = 0.4 
Fig. 1 Interleukin-33 (IL-33) deficiency does not affect Schistosoma mansoni worm maturation and the number of eggs in intestinal tissues. a 
Female IL-33−/− and wild-type (WT)  BALB/cCrSlc (BALB/c) mice (4–8 animals per group) were subcutaneously infected with 50 and 35 S. mansoni 
cercariae for 9 and 12 weeks, respectively, and sacrificed at 4, 6, 9 and 12 weeks post-infection (wpi) to assess the morphology of worms and count 
the number of worm pairs and tissue eggs. b Representative photographs of the morphology of worms recovered from both mouse genotypes 
at weeks 4 (upper panels) and 6 (lower panels) at ×40 magnification. c Number of worm pairs from both IL-33−/− and WT mice. d Number of eggs 
in intestinal tissue. Groups were compared using the unpaired two-tailed t-test with Welch’s correction. Experiments were replicated at least three 
times. Data are representative of 2 independent experiments with similar results and are presented as the mean with standard error of the mean 
(SEM). Significance (P value) is indicated above connector bars between appropriate groups. Mouse groups were compared using the Mann–
Whitney test at the P < 0.05 level of significance
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for IL-13 at 9 and 12  wpi, respectively; Fig.  2a, b). To 
verify whether this impairment was limited to the intes-
tines or was systemic, we isolated immune cells from 
spleens of infected mice and measured IL-5 and IL-13 in 
the supernatants after 72 h of stimulation with SmSEA. 
Surprisingly, while there was no statistical difference 
between IL-33−/− mice and WT mice in terms of the 
production of IL-5 in spleens during the course of infec-
tion (U = 19, P = 0.1949; U = 8, P > 0.999; U = 2, P = 0.8 at 
6, 9 and 12 wpi, respectively; Fig. 2c), there was a statisti-
cally significant difference in the production of IL-13 at 
the sixth week of infection (t(8) = 2.39, P = 0.042; Fig. 2d).
IL‑33 deficiency transiently attenuated egg‑induced 
pathology in intestines of S. mansoni‑infected mice
Although schistosome worms also induce type 2 immu-
nity [16, 17], eggs remain the most potent inducers of 
type 2 immunity and the main cause of the pathology in 
the liver and intestines of infected definitive hosts [11–
13]. A pathogenic role for IL-33 in liver pathology dur-
ing schistosome infections has been reported [26–28]. 
Although none of these studies reported on the role of 
IL-33 in the development of intestinal pathology, stud-
ies related to inflammatory bowel diseases have found 
controversial roles for IL-33 in the development and/
or exacerbation of these diseases, with some reporting 
a protective role for IL-33 [41] and others incriminating 
it in the development or exacerbation of these diseases 
[42, 43]. Given this uncertainty, we investigated whether 
IL-33 deficiency would compromise the development of 
egg-induced pathology in intestinal tissues of infected 
mice. As shown in Fig. 3a, b, IL-33 deficiency was tran-
siently associated with attenuated type 2 inflammatory 
responses in the terminal ilea of IL-33−/− mice compared 
to WT mice, characterized by less infiltration of intes-
tinal tissues by inflammatory cells and a wall thickness 
similar to that of non-infected mice at the sixth week 
of infection (t(3) = 5.897, P = 0.010; Fig.  3b). Moreover, 
the inflammatory infiltrates in IL-33−/− mice contained 
fewer eosinophils than those in WT mice at the sixth 
week of infection (Fig. 3a). Both mouse genotypes did not 
differ in terms of granuloma number (U = 3, P > 0.999 and 
U = 2, P = 0.8 at 9 and 12 wpi, respectively; Fig. 3c) and 
area (U = 0, P = 0.2 and U = 3, P > 0.9999 at 9 and 12 wpi, 
respectively; Fig. 3d). Taken together, these data suggest 
that IL-33 may be more important in initiating—but not 
maintaining−type 2 immunity at mucosal barriers than 
needed systemically and that it is not needed for the 
maintenance of schistosome egg-induced pathology in 
intestines. These results prompted us to speculate that 
IL-25 and TSLP expression might be upregulated in this 
setting to compensate for the absence of IL-33 at later 
infection time points in intestines.
There is no change in IL‑25 and TSLP production 
in the absence of IL‑33 in intestines of infected mice
Individually or synergistically, IL-25, IL-33 and TSLP are 
known to induce tissue type 2 immune responses in dif-
ferent homeostatic and pathologic conditions [39, 40, 44, 
45]. The existence of possible interactions between these 
cytokines has also been suggested [40, 45]. We therefore 
reasoned that, due to IL-33 deficiency, there might be 
compensatory changes in IL-25 and/or TSLP produc-
tion in S. mansoni-infected IL-33−/− mice compared 
to WT mice. As shown in Fig.  4, in the small intestinal 
tissues there was no statistically significant difference in 
the levels of IL-25 (U = 3, P > 0.999; t(4) = 0.185, P = 0.863; 
t(4) = 1.169, P = 0.309 for non-infected and infected mice 
at 6 and 9  wpi, respectively; Fig.  4a) and TSLP (U = 1, 
P = 0.666; t(4) = 0.296, P = 0.781; t(4) = 1.205, P = 0.294 
for non-infected and infected mice at 6 and 9  wpi, 
Fig. 2 IL-33 deficiency is associated with transitory impairment 
of type 2 immunity in mesenteric lymph nodes (MLN) of infected 
mice. Female IL-33−/− and WT BALB/c mice (4–8 animals per group) 
were subcutaneously infected with 50 and 35 S. mansoni cercariae 
for 9 and 12 weeks, respectively, and sacrificed at 6, 9 and 12 wpi. 
Immune cells were isolated from MLNs and spleens of infected and 
non-infected (control) mice and stimulated with S. mansoni soluble 
egg antigens for 72 h at 37 °C, 5%  CO2. IL-5 and IL-13 cytokines 
were measured in cell culture supernatants by enzyme-linked 
immunosorbent assay (ELISA). a IL-5 from MLNs. Comparison by 
unpaired two-tailed t-test with Welch’s correction for 6 wpi. b IL-13 
from MLNs. c IL-5 from spleens. d IL-13 from spleens. Comparison by 
unpaired two-tailed t-test with Welch’s correction for 6 wpi. Data are 
representative of two independent experiments with similar results 
and are presented as the mean with SEM. Significance (P value) is 
indicated above connector bars between appropriate groups. Mouse 
groups were compared using the Mann-Whitney test at the P < 0.05 
level of significance
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respectively; Fig.  4b) between IL-33−/− and WT mice, 
indicating that there is no compensatory changes in IL-25 
and TSLP production in the absence of IL-33. Although 
the levels of IL-25 and TSLP expression in intestinal tis-
sue homogenates tended to increase with S. mansoni 
infection compared to non-infected mice, infected mice 
did not produce enough of these cytokines to reach a sta-
tistically significant difference (Fig. 4a, b).
Previous studies reported an increase in IL-33 lev-
els in the sera of individuals with S. japonicum infec-
tion compared to non-infected individuals [27]. In mice, 
this increase, which starts around week 4 of infection, 
reaches its peak around 8 wpi [26], corresponding with 
the oviposition period. This timeline may indicate that 
schistosome eggs are the major inducers of IL-33 release 
in schistosome infection settings. However, due to the 
functional redundancy of IL-33 with respect to IL-25 and 
TSLP [46], we investigated the kinetics of production of 
these cytokines during an S. mansoni infection. Thus, 
we infected only WT BALB/c mice with S. mansoni cer-
cariae and checked for the release of IL-25, IL-33 and 
TSLP in their intestinal tissues. While the levels of IL-33 
remained constantly higher even in naïve mice, levels 
of IL-25 and TSLP tended to increase with oviposition 
(Additional file 2: Figure S2), indicating that S. mansoni 
eggs may induce the release of IL-25 and TSLP, but not of 
IL-33, in the intestines of infected mice.
Discussion
Studies have shown that both schistosome worms and 
eggs induce type 2 immunity, which is essential for their 
maturation, reproduction and egg excretion [14–18]. 
Deficiency in  CD4+ Th2 cells and their effector cytokines 
IL-4 and IL-13 has been shown to substantially decrease 
or completely abrogate egg excretion as a consequence 
of impaired worm maturation or failed signaling by type 
Fig. 3 IL-33 deficiency transiently attenuated egg-induced pathology in the intestines of infected mice. Female IL-33−/− and WT BALB/c mice were 
subcutaneously infected with 50 and 35 S. mansoni cercariae for 9 and 12 weeks, respectively, and sacrificed at 6, 9 and 12 wpi. Terminal ileum 
fragment was obtained from each infected and non-infected mouse (3 animals per group), fixed in 10% neutral buffered formalin, and processed 
for histology. a Representative hematoxylin and eosin-stained histological sections of terminal ileum from infected and non-infected WT (upper 
panels) and IL-33−/− (lower panels) mice. Scale bar: 200 µm for controls, 60 µm for 6 wpi 100 µm for 9- and 12 wpi. Arrows indicate eosinophils 
in the inflammatory inflitrate. b Intestinal wall thickness (mucosal layer excluded) in microns. Unpaired two-tailed t-test with Welch’s correction 
was used to compare mouse genotypes in controls and infected mouse groups at 6 and 9 wpi, and the Mann–Whitney test was used to compare 
infected mouse groups at 12 wpi. c Number of granulomas per tissue section. d Granuloma area  (mm2). Data are presented as the mean with SEM. 
Significance (P value) is indicated above connector bars between appropriate groups. The level of significance was set at P  < 0.05
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2 effector cytokines [15, 47–49]. Moreover, accumu-
lating evidence suggests that ILC2 and their activating 
cytokines IL-25, IL-33 and TSLP induce adaptive type 2 
immunity independently of IL-4 [23–25]. While no data 
are as yet available on the induction of IL-25, IL-33 and 
TSLP release by migrating schistosomula, it has been 
reported that schistosome eggs induce and/or enhance 
the production of IL-25 and IL-33 [50, 51], indicating that 
schistosome eggs may be orchestrating their excretion 
by inducing the production of alarmin cytokines IL-25, 
IL-33 and TSLP to trigger type 2 immunity, which is 
essential to their excretion. In the present study we found 
that IL-33 deficiency did not affect the maturation of 
worms as at both the early (4 wpi) and later (6 wpi) time 
points the morphology did not differ between worms 
recovered from IL-33−/− and those recovered from WT 
mice (Fig. 1b), suggesting that IL-33 may not be required 
for schistosome worm maturation. Consequently, despite 
a higher number of worm pairs in IL-33−/− mice during 
the course of infection, with a statistical difference at the 
ninth week of infection (Fig. 1c), the number of eggs per 
worm pair did not differ between the mouse genotypes 
(Additional file  1: Figure S1a). Also, despite the num-
ber of tissue eggs being higher in IL-33−/− mice than in 
WT mice, the difference was not statistically significant 
between both mouse genotypes (Fig. 1e; Additional file 1: 
Figure S1b). The number of eggs in tissues paralleled the 
number of worm pairs in both mouse genotypes, explain-
ing the similarity in the number of eggs per worm pairs 
despite a higher number of worm pairs and tissue egg 
numbers in IL-33−/− mice.
Lungs have been shown to be the major site of attrition 
for migrating schistosomula, achieved through different 
mechanisms, including the penetration of schistosomula 
into alveoli and their expulsion through the pulmonary 
tract, and immune-mediated killing of schistosomula [52, 
53]. Lungs are also one of the tissues where constitutive 
IL-33 is abundantly expressed in mice [54]. Schistoso-
mula that enter the alveoli may damage the bronchoal-
veolar epithelium, inducing the release of IL-33 which, 
in turn, may initiate an anti-schistosomula immune 
response, thus contributing to the attrition of schistoso-
mula. This process can result in IL-33−/− mice appear-
ing to be more permissive or susceptible to S. mansoni 
infection, explaining the apparent lower number of worm 
pairs in WT mice compared to IL-33−/− mice (Fig. 1c).
We did not determine worm length, the proportion 
of single worms (males or females), the proportion of 
females in pairs [18, 55] or the number of eggs in the 
feces [14, 15]. However, based on the known morphology 
of worms [35, 56] and known intestinal tissue egg num-
bers [14, 32, 33], we believe that our study design is an 
appropriate alternative approach to looking at the effect 
of IL-33, as a potent initiator of type 2 immunity neces-
sary for schistosome worm maturation, on the matura-
tion of S. mansoni worms and the accumulation of eggs 
in intestinal tissues in the case of failed expulsion [14, 32, 
33].
Yu et  al. [26] reported that the injection of S. japoni-
cum-infected mice with exogenous IL-33 increased the 
number of worms recovered at the sixth week of infec-
tion and also exacerbated the liver pathology by increas-
ing the number and size of liver granulomas. This finding 
may simply mean that as endogenous IL-33 plays a role in 
the development of egg-induced liver pathology [26–28], 
injecting exogenous IL-33 would exacerbate its patho-
genic effects. In the present study, we did not find any 
statistically significant difference in the number of eggs 
per worm pair between IL-33−/− and WT mice (Addi-
tional file 1: Figure S1a). These results corroborate those 
reported by Yu et al. [26] as they did not find a difference 
in the number of eggs per female worm. This result indi-
cates that IL-33 alone may play a negligible role in worm 
maturation and the expulsion of eggs.
While studies related to inflammatory bowel diseases 
have reported controversial roles for IL-33 in the devel-
opment and/or exacerbation of these diseases, with some 
reporting a protective role for IL-33 [31, 41] and others 
incriminating it in the development or exacerbation of 
these diseases [42, 43], to the best of our knowledge there 
has been no report on the role of this cytokine in intes-
tinal pathology during schistosomiasis. Although IL-33 
seemed dispensable for S. mansoni worm maturation 
and the excretion of their eggs, we sought  to determine 
Fig. 4 There is no change in IL-25 and thymic stromal lymphopoietin 
(TSLP) production in the intestines of infected mice. Female IL-33−/− 
and WT BALB/c mice (3 animals per group) were subcutaneously 
infected with 50 S. mansoni cercariae for 9 weeks and sacrificed 
at 6 and 9 wpi. Small intestines were homogenized with the 
gentleMACS Octo Dissociator and the cytokines were measured in 
the homogenate supernatants by ELISA. a IL-25 from infected and 
non-infected mice. b TSLP from infected and non-infected mice. 
Experiments were replicated twice with similar results. Data are 
presented as the mean with SEM. Mouse genotypes were compared 
using the Mann–Whitney test for non-infected mice and the unpaired 
two-tailed t-test with Welch’s correction for infected mice
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whether it may play a significant role in the development 
of egg-induced pathology in the intestines of infected 
mice, as it does in the liver [26–28]. We found that the 
absence of IL-33 transiently impaired type 2 immunity 
in the small intestines of IL-33−/− mice, but not in their 
spleens, characterized by impaired production of IL-5 
and IL-13 cytokines in MLNs in response to stimulation 
with SmSEA (Fig. 2) and attenuated egg-induced inflam-
mation in the ilea of IL-33−/− mice at 6 wpi (Fig. 3a, b). 
These results are in line with findings by Vannella et al. 
[46] who, focusing on the role of alarmin cytokines IL-25, 
IL-33 and TSLP in the development and maintenance of 
type 2 cytokine-driven inflammation and fibrosis in lungs 
and liver, found that ablation of these cytokines singly 
had no significant ameliorating effect on liver pathology. 
However, when all three cytokines were ablated, a sig-
nificant improvement of the pathology could be observed 
in the early phase of the infection, indicating functional 
redundancy among these cytokines. The trends observed 
in the present study are in the same direction, with the 
absence of IL-33 not affecting the development of pathol-
ogy (Fig. 3a) nor the number and size of granulomas in 
the intestines of IL-33−/− mice at time points beyond 
the 6 wpi (Fig.  3c, d). However, the difference between 
the study by Vannella et al. [46] and our study is that we 
started our observations at 6 wpi, when egg-induced type 
2 immunity is still at its start, while Vannella et al. started 
their observations at 9 wpi when egg-induced type 2 
immunity has already reached its peak. We believe that 
Vannella et  al. [46] may have found a significant differ-
ence between IL-33 deficient mice and WT at an earlier 
stage of the infection, as observed in our study.
Despite IL-33 sharing functional redundancy with 
IL-25 and TSLP [46], the former remains the most potent 
of all three cytokines in inducing type 2 immunity [39, 
40, 57]. In addition to inducing type 2 immunity by itself, 
IL-33 can also potentiate the type 2 immunity induced 
by IL-25 and TSLP [58]. Of all the cells that respond to 
IL-33, ILC2 and Th2 are the most important as through 
their production of abundant amounts of the type 2 
cytokines IL-4, IL-5 and IL-13, they play the most impor-
tant role in cell-mediated effector type 2 immunity [59, 
60], characterized by, among others, the accumulation 
of M2 macrophages and eosinophils in affected tissues. 
Although dispersed in all tissues, ILC2 are more abun-
dant in the lungs and intestinal tissues [61], where they 
are the first to be activated by IL-33, subsequently migrat-
ing to local draining lymph nodes to initiate adaptive type 
2 immunity [25, 62]. Thus, it is understandable that the 
absence of IL-33 in IL-33−/− mice at the early stage of the 
patent infection might have left ILC2 inactivated, leading 
to impaired type 2 immunity [59], as seen in the present 
study (Fig. 2a, b). In addition to acting through ILC2 and 
Th2 cells, IL-33 also acts directly on eosinophils, induc-
ing their activation and expansion [63, 64]. Therefore, its 
absence in IL-33−/− mice can explain the small number 
of eosinophils in the inflammatory infiltrates at 6 wpi 
(Fig. 3a, b) [65]. However, due to the persistence of egg-
derived ESP [6–10] as eggs keep accumulating in the tis-
sues, and to the fact that IL-25 and TSLP can induce type 
2 immunity independently of IL-33 [51, 66–68], alterna-
tive mechanisms leading to the activation of both innate 
and adaptive type 2 immunity, including the taking over 
of ILC2 activation by IL-25 and TSLP and Th2-depend-
ent effector pathways, might have been activated to com-
pensate the absence of IL-33 (Figs. 2, 3). Together, these 
alternative mechanisms may have led to improved type 2 
immunity at time points beyond 6 wpi.
Results from various studies have pointed to the exist-
ence of possible interactions between IL-25, IL-33 and 
TSLP [40, 45]. In one study, anti-IL-33 treatment and 
TSLP receptor deficiency blocked the infection-induced 
expression of IL-25 in lung epithelial cells, and ex  vivo 
treatment of ILC2 with TSLP increased their expression 
of IL-25 and IL-33 receptors [45]. In another study, the 
authors noted that IL-25 shared with IL-33 many activi-
ties on macrophages without having additive effects, 
pointing toward the possible existence of common down-
stream signaling pathways for their biological activities 
[40]. This led us to postulate that IL-33 deficiency might 
be associated with a modified production of IL-25 and 
TSLP in the intestines of S. mansoni-infected IL-33−/− 
mice. However, our results show no modification of 
intestinal production of IL-25 and TSLP as their levels 
in intestinal tissue homogenates did not differ between 
mouse genotypes (Fig. 4a, b), meaning that although they 
can, individually or synergistically, induce type 2 immu-
nity, the absence of one may not affect the others in the 
schistosome infection settings or intestines. The nature 
of the interactions and conditions of their occurrence 
between IL-25, IL-33 and TSLP pointed out in the above-
mentioned studies [40, 45] remain to be clarified.
Studies in humans and mice have reported an increase 
of IL-33 levels in the sera of individuals and animals 
infected with S. japonicum [27]. Also, these increased 
levels of IL-33 in serum were found to peak around the 
8th week of infection in mice [26], corresponding to 
the peak of egg-induced immune responses, suggest-
ing that through their ESP, eggs may be the main induc-
ers of IL-33 release in schistosome infections. Indeed, 
Hams et al. [50, 51] reported that injection of S. mansoni 
eggs or the recombinant form of their derived compo-
nents, namely ω1, induced the production of IL-25 and 
IL-33 in the lungs and fat tissue, respectively. Whether 
eggs in intestinal tissues induce the production of IL-33, 
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IL-25 and TSLP is not known. We measured the levels of 
these alarmin cytokines in the intestinal tissue homoge-
nates during S. mansoni infection in WT BALB/c mice 
and found that IL-33 levels remained constantly higher, 
even in non-infected mice (Additional file 2: Figure S2). 
In contrast, IL-25 and TSLP levels fluctuated over the 
course of infection, peaking around the tenth week of 
infection, with TSLP at much lower levels than IL-25 
(Additional file 2: Figure S2). The start of an increase in 
levels of IL-25 and TSLP tended to correspond to that of 
oviposition, suggesting that the latter might be inducing 
the release of IL-25 and TSLP, but not of IL-33. Flamar 
et  al. [62] recently reported that IL-33 expression was 
high in the small intestines of naïve mice, corroborat-
ing our findings, and indicating that IL-33 is constantly 
expressed in high amounts in mouse intestinal tissues.
Conclusions
To the best of our knowledge, this is the first study to 
look at the role of IL-33 in the maturation of S. mansoni 
worms, as well as at the effect of its absence on the accu-
mulation of eggs in the intestinal tissues. It is also the 
first study to report on the role that IL-33 may play in the 
maintenance of egg-induced type 2 immunity in intes-
tines of S. mansoni-infected mice. The results show that 
IL-33 is dispensable for the maturation of S. mansoni and 
that its absence may have a negligible effect on the num-
ber of eggs accumulating in intestinal tissues when they 
fail to exit the intestines. Furthermore, due to transient 
impairment of type 2 immunity observed in the intestines 
but not spleens, this study highlights the importance of 
IL-33 over IL-25 and TSLP in initiating, but not main-
taining, locally induced type 2 immunity in intestinal tis-
sues in schistosome infections. These results corroborate 
previously reported findings that IL-25, IL-33 and TSLP 
may be sharing a partial functional redundancy in their 
ability to maintain tissue-induced type 2 immunity. Their 
combined or sequential ablation might be the best option 
to decipher the role of each of them in schistosomia-
sis and clarify the possible interactions that might exist 
between them.
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